Essential thrombocytosis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Risk factors== | ==Risk factors== | ||
*Most common risk factor in the development of Essential thrombocytosis is age greater than 60 years. Most patients go undiagnosed until late. | *Most common risk factor in the development of Essential thrombocytosis is age greater than 60 years.<ref name="pmid21106990">{{cite journal| author=Beer PA, Erber WN, Campbell PJ, Green AR| title=How I treat essential thrombocythemia. | journal=Blood | year= 2011 | volume= 117 | issue= 5 | pages= 1472-82 | pmid=21106990 | doi=10.1182/blood-2010-08-270033 | pmc=PMC3145107 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21106990 }} </ref> Most patients go undiagnosed until late. | ||
*Other risk factors for ET include: | *Other risk factors for ET include: | ||
**Presence of JAK2 mutation | **Presence of JAK2 mutation | ||
Revision as of 15:38, 5 November 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis risk factors On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis risk factors |
|
Risk calculators and risk factors for Essential thrombocytosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk factors in the development of Essential thrombocytosis are presence of JAK2 gene mutation, high white cell count >15 x 10/L at diagnosis, previous bone marrow fibrosis, age greater than 60 years and female sex.[1]
Risk factors
- Most common risk factor in the development of Essential thrombocytosis is age greater than 60 years.[1] Most patients go undiagnosed until late.
- Other risk factors for ET include:
- Presence of JAK2 mutation
- High white cell count of 15 x 10/L at the time of diagnosis
- Previous history of bone marrow fibrosis
- Female sex
References
- ↑ 1.0 1.1 Beer PA, Erber WN, Campbell PJ, Green AR (2011). "How I treat essential thrombocythemia". Blood. 117 (5): 1472–82. doi:10.1182/blood-2010-08-270033. PMC 3145107. PMID 21106990.